Park-Reeves Syringomyelia Research Consortium

Overview

About this study

The purpose of this research study is to further our understanding of syringomyelia and Chiari malformations. This study is being done to learn about the underlying causes, natural history, and optimal treatment of syringomyelia and Chiari malformations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients with Syringomyelia and Chiari Malformation.

Exclusion Criteria:

Patients who choose not to participate in the study.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/15/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator David Daniels, M.D., Ph.D.	Open for enrollment	Contact information: RST Neurologic Surgery Research Team (507) 293-1963

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

David Daniels, M.D., Ph.D.

Open for enrollment

Contact information:

RST Neurologic Surgery Research Team

(507) 293-1963

More information

Publications

Publications are currently not available

Clinical Trials